Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
International Urology and Nephrology|April 15, 2026
Reanalysis of LUNAR progression-free survival using reconstructed individual patient data: time-varying treatment effectsKenji Tanabe, Soichiro Yoshida, Motohiro Fujiwara, et al.
Clinical Genitourinary Cancer|May 18, 2026
Delayed Progression-Free Survival Benefit of Belzutifan Versus Everolimus in LITESPARK-005: A Reconstructed Time-to-Event ReanalysisMotohiro Fujiwara, Soichiro Yoshida, Shugo Yajima, et al.
Clinical Genitourinary Cancer|May 5, 2015
High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing ProtocolKenji Tanabe, Soichiro Yoshida, Fumitaka Koga, et al.
Cell Reports|August 31, 2022
Non-degradable autophagic vacuoles are indispensable for cell competitionEilma Akter, Yukihiro Tasaki, Yusuke Mori, et al.
Kidney International|December 18, 2023
A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrenceYoko Shirai, Kenichiro Miura, Kiyonobu Ishizuka, et al.
BMC Cancer|October 5, 2023
Prevalence and characteristics of patients with upper urinary tract urothelial carcinoma having potential Lynch syndrome identified by immunohistochemical universal screening and Amsterdam criteria IIKenji Tanabe, Yasukazu Nakanishi, Naoya Okubo, et al.
Plos One|February 25, 2012
The clathrin assembly protein PICALM is required for erythroid maturation and transferrin internalization in miceMai Suzuki, Hirokazu Tanaka, Akira Tanimura, et al.
Japanese Journal of Clinical Oncology|April 29, 2026
Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancerKohei Hirose, Soichiro Yoshida, Wei Chen, et al.
Plos One|October 4, 2014
Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cellsShinya Rai, Hirokazu Tanaka, Mai Suzuki, et al.
Clinical Genitourinary Cancer|September 21, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA StudyHiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, et al.
Pageof 10